Cargando…

Identifying Dopamine D3 Receptor Ligands through Virtual Screening and Exploring the Binding Modes of Hit Compounds

The dopamine D3 receptor (D3R) is an important central nervous system target for treating various neurological diseases. D3R antagonists modulate the improvement of psychostimulant addiction and relapse, while D3R agonists can enhance the response to dopaminergic stimulation and have potential appli...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Hongshan, Wu, Chengjun, Su, Rui, Sun, Tiemin, Li, Xingzhou, Guo, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862751/
https://www.ncbi.nlm.nih.gov/pubmed/36677583
http://dx.doi.org/10.3390/molecules28020527
_version_ 1784875167835488256
author Jin, Hongshan
Wu, Chengjun
Su, Rui
Sun, Tiemin
Li, Xingzhou
Guo, Chun
author_facet Jin, Hongshan
Wu, Chengjun
Su, Rui
Sun, Tiemin
Li, Xingzhou
Guo, Chun
author_sort Jin, Hongshan
collection PubMed
description The dopamine D3 receptor (D3R) is an important central nervous system target for treating various neurological diseases. D3R antagonists modulate the improvement of psychostimulant addiction and relapse, while D3R agonists can enhance the response to dopaminergic stimulation and have potential applications in treating Parkinson’s disease, which highlights the importance of identifying novel D3R ligands. Therefore, we performed auto dock Vina-based virtual screening and D3R-binding-affinity assays to identify human D3R ligands with diverse structures. All molecules in the ChemDiv library (>1,500,000) were narrowed down to a final set of 37 molecules for the binding assays. Twenty-seven compounds exhibited over 50% inhibition of D3R at a concentration of 10 μM, and 23 compounds exhibited over 70% D3R inhibition at a concentration of 10 μM. Thirteen compounds exhibited over 80% inhibition of D3R at a concentration of 10 μM and the IC(50) values were measured. The IC(50) values of the five compounds with the highest D3R-inhibition rates ranged from 0.97 μM to 1.49 μM. These hit compounds exhibited good structural diversity, which prompted us to investigate their D3R-binding modes. After trial and error, we combined unbiased molecular dynamics simulation (MD) and molecular mechanics generalized Born surface area (MM/GBSA) binding free-energy calculations with the reported protein–ligand-binding pose prediction method using induced-fit docking (IFD) and binding pose metadynamics (BPMD) simulations into a self-consistent and computationally efficient method for predicting and verifying the binding poses of the hit ligands to D3R. Using this IFD-BPMD-MD-MM/GBSA method, we obtained more accurate and reliable D3R–ligand-binding poses than were obtained using the reported IFD-BPMD method. This IFD-BPMD-MD-MM/GBSA method provides a novel paradigm and reference for predicting and validating other protein–ligand binding poses.
format Online
Article
Text
id pubmed-9862751
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98627512023-01-22 Identifying Dopamine D3 Receptor Ligands through Virtual Screening and Exploring the Binding Modes of Hit Compounds Jin, Hongshan Wu, Chengjun Su, Rui Sun, Tiemin Li, Xingzhou Guo, Chun Molecules Article The dopamine D3 receptor (D3R) is an important central nervous system target for treating various neurological diseases. D3R antagonists modulate the improvement of psychostimulant addiction and relapse, while D3R agonists can enhance the response to dopaminergic stimulation and have potential applications in treating Parkinson’s disease, which highlights the importance of identifying novel D3R ligands. Therefore, we performed auto dock Vina-based virtual screening and D3R-binding-affinity assays to identify human D3R ligands with diverse structures. All molecules in the ChemDiv library (>1,500,000) were narrowed down to a final set of 37 molecules for the binding assays. Twenty-seven compounds exhibited over 50% inhibition of D3R at a concentration of 10 μM, and 23 compounds exhibited over 70% D3R inhibition at a concentration of 10 μM. Thirteen compounds exhibited over 80% inhibition of D3R at a concentration of 10 μM and the IC(50) values were measured. The IC(50) values of the five compounds with the highest D3R-inhibition rates ranged from 0.97 μM to 1.49 μM. These hit compounds exhibited good structural diversity, which prompted us to investigate their D3R-binding modes. After trial and error, we combined unbiased molecular dynamics simulation (MD) and molecular mechanics generalized Born surface area (MM/GBSA) binding free-energy calculations with the reported protein–ligand-binding pose prediction method using induced-fit docking (IFD) and binding pose metadynamics (BPMD) simulations into a self-consistent and computationally efficient method for predicting and verifying the binding poses of the hit ligands to D3R. Using this IFD-BPMD-MD-MM/GBSA method, we obtained more accurate and reliable D3R–ligand-binding poses than were obtained using the reported IFD-BPMD method. This IFD-BPMD-MD-MM/GBSA method provides a novel paradigm and reference for predicting and validating other protein–ligand binding poses. MDPI 2023-01-05 /pmc/articles/PMC9862751/ /pubmed/36677583 http://dx.doi.org/10.3390/molecules28020527 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jin, Hongshan
Wu, Chengjun
Su, Rui
Sun, Tiemin
Li, Xingzhou
Guo, Chun
Identifying Dopamine D3 Receptor Ligands through Virtual Screening and Exploring the Binding Modes of Hit Compounds
title Identifying Dopamine D3 Receptor Ligands through Virtual Screening and Exploring the Binding Modes of Hit Compounds
title_full Identifying Dopamine D3 Receptor Ligands through Virtual Screening and Exploring the Binding Modes of Hit Compounds
title_fullStr Identifying Dopamine D3 Receptor Ligands through Virtual Screening and Exploring the Binding Modes of Hit Compounds
title_full_unstemmed Identifying Dopamine D3 Receptor Ligands through Virtual Screening and Exploring the Binding Modes of Hit Compounds
title_short Identifying Dopamine D3 Receptor Ligands through Virtual Screening and Exploring the Binding Modes of Hit Compounds
title_sort identifying dopamine d3 receptor ligands through virtual screening and exploring the binding modes of hit compounds
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862751/
https://www.ncbi.nlm.nih.gov/pubmed/36677583
http://dx.doi.org/10.3390/molecules28020527
work_keys_str_mv AT jinhongshan identifyingdopamined3receptorligandsthroughvirtualscreeningandexploringthebindingmodesofhitcompounds
AT wuchengjun identifyingdopamined3receptorligandsthroughvirtualscreeningandexploringthebindingmodesofhitcompounds
AT surui identifyingdopamined3receptorligandsthroughvirtualscreeningandexploringthebindingmodesofhitcompounds
AT suntiemin identifyingdopamined3receptorligandsthroughvirtualscreeningandexploringthebindingmodesofhitcompounds
AT lixingzhou identifyingdopamined3receptorligandsthroughvirtualscreeningandexploringthebindingmodesofhitcompounds
AT guochun identifyingdopamined3receptorligandsthroughvirtualscreeningandexploringthebindingmodesofhitcompounds